Picture of Alkem Laboratories logo

ALKEM Alkem Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line9,54712,59818,42118,44313,048
Depreciation
Non-Cash Items23231.1-1,099-954139
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3,914-9,306-7,418-9,419534
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities7,7975,85112,64911,11016,825
Capital Expenditures-5,292-3,631-1,949-3,389-2,329
Purchase of Fixed Assets
Other Investing Cash Flow Items2,128-3,783-8,036-10,9633,458
Sale of Fixed Assets
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,164-7,414-9,985-14,3511,128
Financing Cash Flow Items-546-651-536-401-905
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,789792-2,7183,796-17,608
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash823-731-17.2580416